XML 97 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Change in Presentation Currency (Tables)
 12 Months Ended
Dec. 31, 2022
Disclosure Of Reclassifications Or Changes In Presentation Text Block Abstract  
Schedule of effect of translation
As at January 1, 2021        
   Previously reported (CAD$)   Translated (USD$) 
Current assets   6,926,844    5,436,341 
Non-current assets   16,516,119    12,918,903 
Total assets   23,442,963    18,355,244 
           
Current liabilities   900,300    707,056 
Non-current liabilities   6,674,405    5,242,229 
Total liabilities   7,574,705    5,949,285 

 

As at December 31, 2021        
   Previously reported (CAD$)   Translated (USD$) 
Current assets   14,651,619    11,556,728 
Non-current assets   187,434,040    147,799,796 
Total assets   202,085,659    159,356,524 
           
Current liabilities   7,510,606    5,924,125 
Non-current liabilities   5,507,178    4,343,886 
Total liabilities   13,017,784    10,268,011 

 
Schedule of consolidated statements of loss and comprehensive loss
   Previously reported (CAD$)   Translated (USD$) 
Expenses        
Accretion   502,291    408,181 
Amortization and depreciation   374,455    298,666 
Consulting   91,161    72,726 
General administrative costs   4,429,209    3,533,474 
Impairment charges   98,345    78,456 
Interest expense   9,365    - 
Office and administrative   247,433    197,391 
Professional fees   728,793    581,408 
Promotion and shareholder communication   208,201    166,096 
Reclamation costs   889,154    709,399 
Travel   33,355    26,609 
Transfer agent and filing fees   167,612    133,717 
Staff costs   1,983,446    1,582,326 
Stock option expense   1,787,046    1,425,645 
Loss from operating expenses   (11,549,866)   (9,214,094)
Interest income   26,307    20,987 
Foreign exchange gain   34,174    27,263 
Loss on divestment of mineral properties   (112,708)   (89,914)
Gain on change in asset retirement obligation estimate   2,155,949    1,719,943 
Loss on contract termination   (3,447,125)   (2,750,000)
Unrealized gain on uranium investment   1,947,939    1,554,000 
Gain on sale of uranium investment   656,928    524,075 
Loss on investment in associate   (445,914)   (355,735)
Net loss for the year   (10,734,316)   (8,563,475)
Exchange differences on translation foreign operations   206,082    (1,325,855)
Other comprehensive loss for the year   (10,528,234)   (9,889,330)
           
Loss per share - basic and diluted   (0.05)   (0.13)